Ethical Considerations in Orphan Drug Approval and Use. A S Kesselheim. Clinical Pharmacology & Therapeutics (2012); 92 2, 153–155. doi:10.1038/clpt.2012.92
We conclude that small studies of appropriate design can support US FDA approval of new medicines for rare diseases.